{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:58:12Z","timestamp":1788382692056,"version":"build-2803163510"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Adigrat University"},{"name":"Addis Pharmaceutical Factory"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Introduction<\/jats:title><jats:p>Orally disintegrating tablet (ODT) is a dosage form that overcomes the problem of swallowing which is prevalent in about 35% of the general population. Co-trimoxazole (CTX) is given for patients with HIV for the prophylaxis of opportunistic infection (OI), commonly for pneumocystis carinii pneumonia. It was reported that CTX was associated with a 25\u201346% reduction in mortality among individuals infected with HIV in sub-Saharan Africa. Esophageal candidiasis which usually comes along with HIV\/AIDS is one of AIDS defining illness affecting up to 1 in 5 of people with AIDS. This opportunistic illness is manifested by painful or difficulty of swallowing. In this respect, CTX ODT offer the advantages of both liquid dosage forms in terms of easy swallowing thereby improve patient compliance and solid dosage forms in terms of dose uniformity, stability, lower production, and transportation costs. The objective of this study was to formulate, characterize and optimize CTX ODT which could overcome swallowing problem and improve patient compliance. Co-trimoxazole ODTs were prepared by direct compression technique using a semi synthetic super disintegrant (crospovidone) along with other excipients. Two taste masking techniques were employed, addition of sweetening agent, and solid dispersion by using a pH sensitive polymer, Eudragit E-100 at different ratios (1:1, 1:2 and 1:3). Taste masking was determined by comparing taste threshold value and<jats:italic>in vitro<\/jats:italic>drug release. Preliminary study was used to investigate the effect of crospovidone, compression force (CF) and Hydroxypropyl cellulose (HPC) on disintegration time, friability and wetting time (WT). Factorial design was used as it enables simultaneous evaluation of formulation variables and their interaction effect. From the preliminary study, the factors that were found significant were further optimized using central composite design. Design-Expert 8.0.7.1 software was employed to carry out the experimental design. The bitterness threshold concentration of Trimethoprim was found to be 150 \u03bcg\/ml and the<jats:italic>in vitro<\/jats:italic>drug release of the three batches of drug to polymer ratio (F1:1, 1:2 and 1:3) was 2.80\u00b10.05, 2.77\u00b10.00 and 2.63\u00b10.00 respectively. From the optimization study, the optimal concentration for the superdisintegrant was 8.60% w\/w and a CF of 11.25 KN which gave a rapid disintegration and WT of 13.79 and 23.19 seconds respectively and a friability of 0.666%.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Conclusion<\/jats:title><jats:p>In this study, co-trimoxazole ODT was formulated successfully. Central composite design was effectively used to model and optimize friability, DT and WT. The method was found effective for estimating the effect of independent variables on the dependent variables by using polynomial equation and surface plots. Optimization of the response variables was possible by using both numerical and graphical optimization and the predicted optimal conditions were confirmed experimentally and were found to be in good agreement within 5% of the predicted responses. The results of the study showed that CTX ODT had significantly rapid disintegration, less than 1% friability and enhanced dissolution profiles. The successful formulation of CTX ODT can solve difficulty of swallowing of conventional tablets for some group of patients which are unable to swallow solid oral dosage form.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0246648","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T17:59:31Z","timestamp":1615917571000},"page":"e0246648","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-5704","authenticated-orcid":true,"given":"Chernet","family":"Tafere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewdu","family":"Yilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Abrha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3207-8369","authenticated-orcid":true,"given":"Adane","family":"Yehualaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"issue":"3","key":"pone.0246648.ref001","first-page":"1","article-title":"A review on immediate release tablet dosage form","volume":"2","author":"JA Ahmed","year":"2015","journal-title":"IJPPR"},{"issue":"1","key":"pone.0246648.ref002","first-page":"78","article-title":"a Review on immediate release drug delivery system","volume":"4","author":"B Neeraj","year":"2014","journal-title":"IRJPAS"},{"issue":"4","key":"pone.0246648.ref003","first-page":"4","article-title":"Orally disintegrating dosage forms: Breakthrough solution for non-compliance","volume":"5","author":"KB Liew","year":"2013","journal-title":"Int J Pharm Pharm Sc"},{"issue":"6","key":"pone.0246648.ref004","first-page":"428","article-title":"A review on immediate release drug delivery system","volume":"7","author":"PS Malpure","year":"2018","journal-title":"WJPPS"},{"issue":"4","key":"pone.0246648.ref005","first-page":"677","article-title":"Formulation and taste masking of ranitidine orally disintegrating tablet","volume":"15","author":"Z Hesari","year":"2016","journal-title":"Iran J Pharm Res"},{"issue":"2","key":"pone.0246648.ref006","first-page":"35","article-title":"Orally disintegrating tablets\u2014friendly to pediatrics and geriatrics","volume":"2","author":"R Pahwa","year":"2010","journal-title":"Arch Apll Sci Res"},{"issue":"2","key":"pone.0246648.ref007","first-page":"1","article-title":"Oral disintegrating tablets: An overview","volume":"1","author":"S Velmurugan","year":"2010","journal-title":"IJCPS"},{"issue":"1","key":"pone.0246648.ref008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.25141\/2471-6782-2016-1.0053","article-title":"Formulation and evaluation of Meclizine Hcl orally dispersible tablets by using natural super disintegrants","volume":"2","author":"MV Kumar","year":"2016","journal-title":"IJPSR"},{"issue":"5","key":"pone.0246648.ref009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.22270\/jddt.v8i5.1888","article-title":"A review on fast dissolving tablet","volume":"8","author":"R Rahane","year":"2018","journal-title":"JDDT"},{"issue":"2","key":"pone.0246648.ref010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1208\/s12249-015-0313-1","article-title":"Orally disintegrating films and mini-tablets\u2014innovative dosage forms of choice for pediatric use","volume":"16","author":"M Preis","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"pone.0246648.ref011","first-page":"35","article-title":"Orally disintegrating tablets: formulation, preparation techniques and evaluation","volume":"1","author":"P Nagar","year":"2011","journal-title":"J Appl Pharm Sci"},{"key":"pone.0246648.ref012","volume-title":"Guidance for Industry: Orally Disintegrating Tablets","author":"FDA","year":"2008"},{"issue":"4","key":"pone.0246648.ref013","first-page":"27","article-title":"Formulation & evaluation of orally disintegrating tablet of ibuprofen for paediatric use","volume":"5","author":"A Jadhav","year":"2016","journal-title":"CJPS"},{"key":"pone.0246648.ref014","first-page":"167","article-title":"Advantages and Quality Control of Orally Disintegrating Tablets","volume":"34","author":"SS \u00d6lmez","year":"2009","journal-title":"FABAD J Pharm Sci"},{"issue":"1","key":"pone.0246648.ref015","first-page":"50","article-title":"Oral Disintegrating Tablets: A Review","volume":"5","author":"P Pandey","year":"2016","journal-title":"IJPRR"},{"issue":"2","key":"pone.0246648.ref016","first-page":"68","article-title":"Orodispersible Tablet of Proton Pump Inhibitor Drugs: A Review","volume":"3","author":"P Poojan","year":"2013","journal-title":"JPSBR"},{"key":"pone.0246648.ref017","author":"WHO","year":"2010","journal-title":"Dispersible Tablets"},{"issue":"5","key":"pone.0246648.ref018","first-page":"682","article-title":"Evaluation of gum from Abelmoschus esculentus leaves as a suspending agent in cotrimoxazole suspension formulation","volume":"7","author":"JI Ordu","year":"2018","journal-title":"J pharm Innov"},{"issue":"1","key":"pone.0246648.ref019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.15640\/jcb.v3n1a5","article-title":"Analytical method development for the spectrophotometric determination of sulfamethoxazole in bulk drug and pharmaceutical preparation","volume":"3","author":"ZS Mehdi","year":"2015","journal-title":"JCB"},{"issue":"7","key":"pone.0246648.ref020","first-page":"13","article-title":"Enhancement of oral bioavailability and solid dispersion: A review","volume":"1","author":"N Saffoon","year":"2011","journal-title":"J Appl Pharm Sci"},{"key":"pone.0246648.ref021","first-page":"87","article-title":"Comparison of dissolution profiles of two commercially available co-trimoxazole tablets","volume":"33","author":"Sayar E","year":"2008","journal-title":"FABAD J Pharm Sci"},{"issue":"3","key":"pone.0246648.ref022","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/dkt400","article-title":"Serum concentration of co-trimoxazole during a high-dosage regimen","volume":"69","author":"AS Muhammed","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"pone.0246648.ref023","article-title":"Co-trimoxazole management and availability logistics and supply chain experience in 15 u.s. president\u2019s emergency plan for aids relief countries","author":"Nersesian","year":"2011"},{"issue":"1","key":"pone.0246648.ref024","first-page":"1598","volume":"6","author":"D Mekonnin","year":"2015","journal-title":"Evaluation of Prophylactic Use of Cotrimoxazole for People Living with HIV \/ AIDS. IJPTP"},{"key":"pone.0246648.ref025","author":"WHO","year":"2006","journal-title":"Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults"},{"key":"pone.0246648.ref026","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2471\/BLT.09.066522","article-title":"Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV","author":"A Date","year":"2010","journal-title":"Bull World Heal organ"},{"key":"pone.0246648.ref027","article-title":"Oral candidiasis and HIV disease","author":"Project Inform","year":"2011","journal-title":"Project Inform"},{"key":"pone.0246648.ref028","volume-title":"Report of the informal expert meeting on dosage forms of medicines for children","author":"WHO","year":"2008"},{"issue":"3","key":"pone.0246648.ref029","first-page":"374","article-title":"Formulation development and evaluation of taste masked orally disintegrating tablets of perindopril erbumine by direct compression method","volume":"4","author":"Mukesh","year":"2012","journal-title":"IJDDR"},{"issue":"2","key":"pone.0246648.ref030","first-page":"47","volume":"7","author":"AP Kulkarni","year":"2012","journal-title":"Development of Oral Disintegrating Tablet of Rizatriptan Benzoate with Inhibited Bitter Taste"},{"issue":"1","key":"pone.0246648.ref031","first-page":"21","article-title":"Formulation and evaluation of orally disintegrating tablet of Rizatriptan using natural superdisintegrant","volume":"3","author":"M Tabbakhian","year":"2014","journal-title":"J HerbMed Pharmacol"},{"key":"pone.0246648.ref032","volume-title":"United State Pharmacopoeia 30-National Formulary 25","author":"USP30-NF25","year":"2007"},{"issue":"1","key":"pone.0246648.ref033","first-page":"827","article-title":"Boswellia papyrifera resin as microencapsulating agent for controlled release of diclofenac sodium: formulation, evaluation and optimization study","volume":"6","author":"F Molla","year":"2014","journal-title":"Int J Pharm Pharm Sci"},{"issue":"2","key":"pone.0246648.ref034","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejpb.2011.10.019","article-title":"Taste masking of paracetamol by hot-melt extrusion: An in vitro and in vivo evaluation","volume":"80","author":"M Maniruzzaman","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"pone.0246648.ref035","first-page":"167","article-title":"Preparation, Characterization and Dissolution of Solid Dispersion of Diclofenac Sodium Using Eudragit E-100","volume":"3","author":"E Jafari","year":"2013","journal-title":"J Appl Pharm Sci"},{"issue":"11","key":"pone.0246648.ref036","first-page":"1","article-title":"Formulation and evaluation of taste masked fast disintegrating tablet of promethazine hydrochloride","volume":"3","author":"S Kolhe","year":"2013","journal-title":"LOSR J Pharm"},{"issue":"1","key":"pone.0246648.ref037","first-page":"1","article-title":"A Review on new generation orodispersible tablets and its future prospective","volume":"3","author":"T Ghosh","year":"2011","journal-title":"Int J Pharm Pharm Sci"},{"issue":"1","key":"pone.0246648.ref038","first-page":"40","article-title":"Comparative Study of Superdisintegrants Using Antiemetic Drug As a Model","volume":"5","author":"DS Sandeep","year":"2015","journal-title":"NUJHS"},{"issue":"1","key":"pone.0246648.ref039","first-page":"155","article-title":"Contrasting the crospovidones functionality as excipients for direct compression","volume":"51","author":"DG Ram\u00edrez","year":"2015","journal-title":"BJPS"},{"issue":"1\u20132","key":"pone.0246648.ref040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2012.03.021","article-title":"Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets","volume":"430","author":"RM Pabari","year":"2012","journal-title":"INT J Pharamaceut"},{"issue":"3","key":"pone.0246648.ref041","first-page":"295","article-title":"Fast dispersible ibuprofen tablets","volume":"15","author":"S Schiermeier","year":"2002","journal-title":"EJPS"},{"key":"pone.0246648.ref042","author":"D Berthoumieu","year":"2010","journal-title":"Tabletting study for ODTs [Internet]"},{"issue":"2","key":"pone.0246648.ref043","first-page":"143","article-title":"Excipients used in the formulation of tablets","volume":"5","author":"V Karthik","year":"2016","journal-title":"J Chem"},{"issue":"4","key":"pone.0246648.ref044","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1208\/pt0804092","article-title":"Physical mechanical and tablet formation properties of hydroxypropylcellulose: In pure form and in mixtures","volume":"8","author":"KM Picker-freyer","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"pone.0246648.ref045","article-title":"Handbook of Pharmaceutical Excipients: Pharmaceutical Excipients","author":"RC Rowe","year":"2012","journal-title":"American Pharmacists Association"},{"issue":"3","key":"pone.0246648.ref046","first-page":"1893","article-title":"Formulation, evaluation and optimization of orally disintegrating tablet of piroxicam","volume":"2","author":"BG Prajapati","year":"2010","journal-title":"IntJ PharmTech Res"},{"issue":"2","key":"pone.0246648.ref047","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0973-8398.84551","article-title":"Design and in-vitro evaluation of mouth","volume":"5","author":"MK Maheswarappa","year":"2011","journal-title":"AJP"},{"issue":"3","key":"pone.0246648.ref048","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0975-1483.100021","article-title":"Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets","volume":"4","author":"RM Pabari","year":"2012","journal-title":"JYP"},{"issue":"1","key":"pone.0246648.ref049","first-page":"21","article-title":"Selecting the Right Central Composite Design","volume":"5","author":"BA Oyejola","year":"2015","journal-title":"Int J Stat App"},{"issue":"1","key":"pone.0246648.ref050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cej.2010.09.010","article-title":"Experimental design and response surface modeling for optimization of Rhodamine B removal from water by magnetic nanocomposite","volume":"165","author":"KP Singh","year":"2010","journal-title":"Chem Eng J"},{"key":"pone.0246648.ref051","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.energy.2017.03.122","article-title":"Modeling and optimization of Fischer-Tropsch synthesis over Co-Mn- Ce \/ SiO 2 catalyst using hybrid RSM \/ LHHW approaches","volume":"128","author":"H Zohdi-fasaei","year":"2017","journal-title":"Energy"},{"issue":"5","key":"pone.0246648.ref052","first-page":"1877","article-title":"Formulation and optimization of sustained release floating matrix tablets of salbutamol sulphate using xanthan gum and hydroxypropyl methylcellulose polymer blend","volume":"6","author":"Z Yilma","year":"2015","journal-title":"IJPSR"},{"issue":"10","key":"pone.0246648.ref053","first-page":"89","article-title":"Statistical, diagnostic and response surface analysis of nefopam hydrochloride nanospheres using 35 box-behnken design","volume":"7","author":"S Singh","year":"2015","journal-title":"Int J Pharm Pharm Sci"},{"issue":"2","key":"pone.0246648.ref054","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.energy.2010.11.034","article-title":"Application of response surface methodology to optimize and investigate the effects of operating conditions on the performance of DMFC","volume":"36","author":"I Taymaz","year":"2011","journal-title":"Energy"},{"issue":"1","key":"pone.0246648.ref055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-7439(98)00065-3","article-title":"Experimental design and optimization","volume":"42","author":"T Lundstedt","year":"1998","journal-title":"Chemom Intell Lab Syst"},{"issue":"2","key":"pone.0246648.ref056","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jhazmat.2008.07.090","article-title":"Application of response surface methodology (RSM) to optimize coagulation\u2013flocculation treatment of leachate using poly-aluminum chloride (PAC) and alum","volume":"163","author":"S Ghafari","year":"2009","journal-title":"J Hazard Mater"},{"issue":"4","key":"pone.0246648.ref057","first-page":"1165","article-title":"Design optimization of a current mirror amplifier integrated circuit using a computational statistics technique","volume":"79","author":"Y Li","year":"2008","journal-title":"IMACS"},{"key":"pone.0246648.ref058","first-page":"243","article-title":"Optimization and characterization of controlled release pellets coated with an experimental latex: I","volume":"125","author":"SK Singh","year":"1995","journal-title":"Anionic drug. J Pharm"},{"issue":"3","key":"pone.0246648.ref059","first-page":"102","article-title":"Formulation and evaluation of orally disintegrating tablet of ondansetron using natural superdisintegrant","volume":"4","author":"MA Shahtalebi","year":"2015","journal-title":"J HerbMed Pharmacol"},{"key":"pone.0246648.ref060","first-page":"89","article-title":"Optimization and characterization of controlled release multi-particulate beads coated with starch acetate","volume":"294","author":"MTH Nutan","year":"2005","journal-title":"IJP"},{"issue":"3","key":"pone.0246648.ref061","first-page":"191","article-title":"Optimization of the face milling process selection parameter using desirability technique for Al-Sic composites","volume":"6","author":"GV Jai","year":"2011","journal-title":"J Manuf Engi"},{"issue":"1","key":"pone.0246648.ref062","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.optlastec.2007.03.009","article-title":"Multi-response optimization of CO 2 laser-welding process of austenitic stainless steel","volume":"40","author":"KY Benyounis","year":"2008","journal-title":"Opt Laser Technol"},{"issue":"5","key":"pone.0246648.ref063","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.matdes.2010.12.025","article-title":"Predicting tensile strength, hardness and corrosion rate of friction stir welded AA6061-T 6 aluminium alloy joints","volume":"32","author":"S Rajakumar","year":"2011","journal-title":"Mater Des"},{"issue":"6","key":"pone.0246648.ref064","first-page":"2625","article-title":"Response surface methodology and desirability analysis for optimizing \u03bc-WEDM parameters for Al6351\/20%Al2O3 composite","volume":"7","author":"R Adalarasan","year":"2015","journal-title":"IntJ ChemTech Res"},{"issue":"3","key":"pone.0246648.ref065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.biortech.2009.09.013","article-title":"Bioresource technology A statistical experiment design approach for optimizing biodegradation of weathered crude oil in coastal sediments","volume":"101","author":"L Mohajeri","year":"2010","journal-title":"Bioresour Technol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T07:20:57Z","timestamp":1698045657000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246648"}},"subtitle":[],"editor":[{"given":"Girish","family":"Sailor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0246648","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]}}}